Matinas BioPharma Receives Notice of Default from NYSE



Matinas BioPharma Receives Notice of Default from NYSE



Source link

  • Related Posts

    Natera’s chief legal officer sold $1.09 million in stock Via Investing.com

    Daniel Rabinowitz, the Secretary and Chief Legal Officer of Natera, Inc. (NASDAQ:NTRA), recently sold a large portion of his holdings in the company. The sale comes as Natera’s stock trades…

    Meta orders removal of tampons from men’s rooms amid Zuckerberg’s post-election shakeup: report

    Jason Miller, senior adviser on the Trump-Vance transition, discusses the push for a dismissal in Trump’s New York criminal case, Hunter Biden’s pardon and the potential roles some prominent public…

    Leave a Reply

    Your email address will not be published. Required fields are marked *